Press Releases Year None20202019201820172015 April 27, 2020 ORIC Pharmaceuticals Presents Preclinical Data on CD73 Inhibitor at the American Association for Cancer Research (AACR) Virtual Annual Meeting April 23, 2020 ORIC Pharmaceuticals Announces Pricing of Initial Public Offering April 2, 2020 ORIC Pharmaceuticals Appoints Christian V. Kuhlen, M.D., as General Counsel March 2, 2020 ORIC Pharmaceuticals Appoints Mardi C. Dier to its Board of Directors January 27, 2020 ORIC Pharmaceuticals Announces First Patient Dosed in Phase 1b Clinical Trial of ORIC-101 in Combination with XTANDI® for the Treatment of Prostate Cancer in Collaboration with Astellas January 2, 2020 ORIC Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 16 of 16
